This inventor holds 3 USPTO granted patents and 8 published patent applications. Top assignees: Beone Medicines | Gmbh, Beone Medicines I Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Changxin Huo: Innovator in Biopharmaceuticals
Introduction
Changxin Huo is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative compounds for targeted protein degradation. His work is crucial in advancing therapeutic strategies for various diseases.
Latest Patents
Changxin Huo holds a patent for the "Degradation of bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use." This patent discloses novel bifunctional compounds formed by conjugating BTK inhibitor moieties with E3 ligase ligand moieties. These compounds function to recruit targeted proteins to E3 ubiquitin ligase for degradation, providing new methods of preparation and use in therapeutic applications. He has 1 patent to his name.
Career Highlights
Changxin Huo is currently associated with Beone Medicines I GmbH, where he continues to push the boundaries of innovation in drug development. His expertise in biochemistry and pharmacology has positioned him as a key figure in his field.
Collaborations
He has collaborated with notable colleagues, including Hexiang Wang and Ruipeng Qi, to further enhance the impact of his research and innovations.
Conclusion
Changxin Huo's contributions to the field of biopharmaceuticals exemplify the importance of innovation in developing new therapeutic strategies. His work continues to inspire advancements in medical science and drug development.